Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01909557
What this trial is testing

Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

Who this might be right for
Quality of LifeDaily ActivityFatigue
University of Catania 62
Post-approval studies (Phase 4)Study completedNCT01195181
What this trial is testing

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Who this might be right for
Hepatitis C VirusChronic Liver DiseaseViral Hepatitis+2 more
Azienda Ospedaliera di Padova 506
Post-approval studies (Phase 4)Study completedNCT00266318
What this trial is testing

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Who this might be right for
Hepatitis C
Beth Israel Medical Center 40
Post-approval studies (Phase 4)Study completedNCT01684787
What this trial is testing

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Who this might be right for
Chronic Hepatitis C
Miguel Santin 80
Not applicableUnknownNCT05751889
What this trial is testing

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

Who this might be right for
Viral Hepatitis C
National Taiwan University Hospital 1,320
Not applicableStudy completedNCT01416610
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Not applicableStudy completedNCT00596960
What this trial is testing

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Who this might be right for
Alcohol DependenceChronic Hepatitis C
US Department of Veterans Affairs 139
Not applicableStudy completedNCT01200225
What this trial is testing

An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,155
Not applicableStudy completedNCT00916474
What this trial is testing

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 408
Post-approval studies (Phase 4)WithdrawnNCT03791814
What this trial is testing

A Prospective Cohort Study to Improve HCV Care in Dialysis Patients

Who this might be right for
Hepatitis C
Albert Einstein Healthcare Network
Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Not applicableStudy completedNCT00004851
What this trial is testing

Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

Who this might be right for
Hepatitis C
National Institutes of Health Clinical Center (CC) 1
Early research (Phase 1)Study completedNCT01930058
What this trial is testing

Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 9
Testing effectiveness (Phase 2)Study completedNCT00097435
What this trial is testing

Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Human Genome Sciences Inc. 115
Large-scale testing (Phase 3)Study completedNCT02634008
What this trial is testing

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

Who this might be right for
Hepatitis C, Acute
Kirby Institute 83
Not applicableUnknownNCT01271140
What this trial is testing

High Dose Insulin Therapy to Improve Liver Function

Who this might be right for
Hepatitis C Virus
McGill University Health Centre/Research Institute of the McGill University Health Centre 5
Post-approval studies (Phase 4)Study completedNCT01045278
What this trial is testing

Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy

Who this might be right for
Hepatitis C
Region Skane 277
Not applicableStudy completedNCT02472925
What this trial is testing

Way to Cure HCV Adherence

Who this might be right for
Hepatitis C
University of Pennsylvania 60
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Next Page